tiprankstipranks
Trending News
More News >
eFFECTOR Therapeutics (EFTR)
OTHER OTC:EFTR
US Market

eFFECTOR Therapeutics (EFTR) Income Statement

Compare
265 Followers

eFFECTOR Therapeutics Income Statement

Last quarter (Q1 2024), eFFECTOR Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, eFFECTOR Therapeutics's net income was $-8.83M. See eFFECTOR Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 3.55M$ 1.43M$ 42.00M$ 0.00
Gross Profit
$ -111.00K$ 3.50M$ 1.41M$ 42.00M$ -307.00K
Operating Expenses
$ 33.84M$ 35.90M$ 33.30M$ 26.18M$ 28.30M
Depreciation and Amortization
$ 111.00K$ 53.00K$ 24.00K$ 160.00K$ 307.00K
EBITDA
$ -32.78M$ -20.36M$ 17.59M$ 16.05M$ -28.05M
Operating Income
$ -33.84M$ -32.40M$ -33.33M$ 15.82M$ -28.61M
Other Income/Expenses
$ -1.97M$ 9.74M$ 0.00$ -1.26M$ -1.13M
Pretax Income
$ -35.81M$ -22.66M$ 15.80M$ 14.56M$ -29.74M
Net Income
$ -35.81M$ -12.93M$ 15.80M$ 14.21M$ -29.74M
Per Share Metrics
Basic EPS
$ -16.37$ -7.85$ 9.78$ 0.28$ -539.08
Diluted EPS
$ -16.37$ -7.85$ 9.78$ 0.10$ -539.08
Weighted Average Shares Outstanding
2.19M 1.65M 1.62M 598.56K 55.17K
Weighted Average Shares Outstanding (Diluted)
2.19M 1.65M 1.62M 598.56K 55.17K
Currency in USD

eFFECTOR Therapeutics Earnings and Revenue History